Free shipping on all orders over $ 500

BMY-14802

Cat. No. M7669
BMY-14802 Structure
Size Price Availability
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BMY-14802 is a potent and selective sigma-1 (σ1) receptor antagonist with an IC50 value of approximately 100 nM. BMY-14802 shows low affinity at serotonin (5-HT) 1A and adrenergic σ1 receptors and minimal activity at dopamine receptors. BMY-14802 has exhibited antipsychotic activity in rodent models and anti-dyskinetic effects against L-DOPA with preservation of antiparkinsonian efficacy.

Chemical Information
Molecular Weight 348.39
Formula C18H22F2N4O
CAS Number 105565-56-8
Solubility (25°C) DMSO: 5 mg/mL (warmed)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Nirmal Bhide, et al. The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat

[2] Melanie A Paquette, et al. The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism

[3] S A Vanecek, et al. Discriminative stimulus characteristics of BMY 14802 in the pigeon

[4] D P Taylor, et al. A role for sigma binding in the antipsychotic profile of BMY 14802?

[5] G R Gewirtz, et al. BMY 14802, a sigma receptor ligand for the treatment of schizophrenia

Related Sigma Receptor Products
ANAVEX 3-71

ANAVEX 3-71 is an orally active SIGMAR1 receptor agonist and M1-positive variant modulator for studies related to schizophrenia.

Blarcamesine

Blarcamesine is a Sigma-1 receptor agonist and muscarinic receptor modulator with neuroprotective and antidepressant activity. In addition, Blarcamesine ameliorates neurological impairment in a mouse model of Rett syndrome.

AB10

AB10 is a selective S1R antagonist.

WLB-89462

WLB-89462 is a selective σ2 receptor ligand (Ki: 13 nM).

Siramesine fumarate

Siramesine (Lu 28-179) fumarate is a potent sigma-2 receptor agonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: BMY-14802 supplier, Sigma Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.